ORASURE TECHNOLOGIES

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

08 11 2022 15:05:01 提供 Nasdaq GlobeNewswire

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

03 11 2022 08:15:00 提供 Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store

02 11 2022 06:05:00 提供 Nasdaq GlobeNewswire

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET

01 11 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

28 9 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

20 9 2022 15:05:00 提供 Nasdaq GlobeNewswire

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

14 9 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

09 8 2022 15:05:02 提供 Nasdaq GlobeNewswire

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

02 8 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

28 7 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

14 7 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 6 2022 15:05:00 提供 Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

25 5 2022 06:05:00 提供 Nasdaq GlobeNewswire

Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

23 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

17 5 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

10 5 2022 15:05:01 提供 Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

03 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

07 4 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

31 3 2022 06:05:00 提供 Nasdaq GlobeNewswire

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

22 3 2022 15:05:00 提供 Nasdaq GlobeNewswire